A new cell therapy could finally bring meaningful relief to patients with the progressive neurodegenerative movement disorder.

Researchers examined enrollment data from 1985 through 2019 for 53 medical schools.

Autism expert Somer Bishop talks about the latest autism research and UCSF's approach to care for the neurodiverse population.

When injected into a tumor, cowpea mosaic virus triggers the immune system to treat the cancer and prevents it from recurring.

This silent killer claims 400 people a year, and causes another 20K emergency room visits.

A UCSF-led study shows inflated risk in people with psychosis, substance abuse and anxiety.

UC Riverside experts on how to proceed with masking when mandates are no longer in effect.

Study suggests new mechanism for how psychedelics affect the brain.

Study ties chronic JUUL use to inflammatory changes across body; results depend on e-cigarette flavor.

Health professional schools across the UC system again achieved strong rankings in U.S. News & World Report’s Best Graduate Schools for 2023.

The new trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.

A new finding could hasten development of lab-grown blood vessels and other tissues to replace and regenerate damaged tissues in human patients.